DAJY(002030)2022-12-07 08:16Company Overview - The company, Daan Gene Co., Ltd., originated from Sun Yat-sen University and was established in 1991 as a technology development company [2][3] - The company transitioned from providing PCR technology services to developing qualitative PCR reagents [3] Historical Milestones - In 1999, the company received the first domestic new drug certificate for its hepatitis B virus nucleic acid (PCR) fluorescent detection kit, which was also the first commercialized diagnostic kit of its kind internationally [3] - The company underwent a share reform in 2000 and was listed on the Shenzhen Stock Exchange in 2004 [3] Laboratory Performance - The independent laboratory sector has experienced significant growth, maintaining an annual growth rate of over 30%, while the company's independent laboratory growth rate is approximately 38% [3] - The independent laboratory reached breakeven last year, with expectations to maintain growth at industry average levels in the coming years [3] Clientele - The primary clients of the independent laboratory are secondary hospitals and below [4] Technology Applications - Second-generation gene sequencing technology is applied in various fields, including tumor disease diagnosis, genetic disease testing, prenatal screening, and pharmacogenomics [4] Competitive Landscape - Domestic gene diagnostic technology is relatively strong in clinical applications, while foreign companies lead in research technology [4] Product Categories - The company's products are categorized into four main types: 1. Molecular diagnostic products primarily based on PCR 2. Immunological products based on the Elisa technology platform 3. Time-resolved products 4. Instrumentation products [4] Future Growth Focus - The company aims to focus on industrial layout and is investing in specialized companies along the industry chain through equity participation [4]